What is ACRV's dilution risk score?

ACRV has a latest available DilutionScore record of 42/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ACRV, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ACRV?

DilutionWatch tracks 25 SEC filing types for ACRV including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ACRV shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ACRV, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ACRV tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ACRV. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ACRV Dilution Risk Score: 42/100

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

40

📊Float Risk—

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for ACRV.

🔔 Track ACRV — Get forecast alerts →

Market Data

Market CapN/A

Shares Outstanding42.85M

Float16.87M

Cash$89.96M

DebtN/A

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	42/100	DilutionWatch score record
Shares Outstanding	42.85M	Verified float table or market cache
Public Float	16.87M	Verified float table or market cache
Market Cap	Not available	Market data cache
Cash Runway	15.8 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 3, FORM 4 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 0.3% shares (2026Q1 vs prior)

45 institutional holders · 17.57M shares

#1 RA CAPITAL MANAGEMENT, L.P. 8.34M shares

#2 Sands Capital Alternatives, LLC 2.12M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 1.44M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.20M

Days to Cover4.9

% of Float7.1%

FINRA data as of Sep 15, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31

3 FORM3 2026-09-02

4 INSIDER TRANSACTION 2026-09-02

4 INSIDER TRANSACTION 2026-08-27

Form 4 INSIDER TRANSACTION 2026-08-25

Full SEC filing analysis available with free account →

Recent News

What Makes Acrivon Therapeutics, Inc. (ACRV) a New Buy Stock Yahoo Finance · Sep 15

Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy Zacks · Aug 24

Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Base GlobeNewswire · Jul 21

Factual ACRV Dilution Snapshot

Acrivon Therapeutics, Inc. (ACRV) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: September 28, 2026.

Recent SEC activity tracked for ACRV: 3 on 2026-09-02; 4 on 2026-09-02; 4 on 2026-08-27.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,439+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

More Research for ACRV

ACRV FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

ACRV — Acrivon Therapeutics, Inc. Dilution Risk Tracker